Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tetraspanin-17 (TSPAN17) is a member of the tetraspanin (transmembrane 4 superfamily) proteins, characterized by four highly conserved transmembrane domains and typically 22–39 kDa in size[1][4]. The gene encodes a protein that is part of the TspanC8 subgroup, which can interact with and regulate the trafficking, maturation, and substrate specificity of the metalloprotease ADAM10[1]. By interacting with ADAM10, TSPAN17 likely influences the expression of cell-surface molecules such as VE-cadherin and may facilitate processes like leukocyte transmigration in endothelial cells[1]. The precise biological roles and clinical significance of TSPAN17 remain incompletely defined, though similar tetraspanins are known to organize membrane complexes, modulate partner protein function, and regulate signal transduction[2][4]. Associations with autoimmune atherosclerosis have been reported, but specific drug interactions, mechanisms of action, or biomarker roles are not established[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tetraspanin-17 (TSPAN17).